Linked Life Data

17551313

Source:http://linkedlifedata.com/resource/pubmed/id/17551313

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
3
pubmed:dateCreated
2007-6-6
pubmed:abstractText
Biliary cancer has a poor prognosis and lacks a standard palliative chemotherapy. The purpose of this prospective single-arm phase II study was to determine the activity and tolerability of irinotecan, 5-fluorouracil, and folinic acid in advanced biliary cancer.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jun
pubmed:issn
1537-453X
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
30
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
319-24
pubmed:dateRevised
2010-3-23
pubmed:meshHeading
pubmed:year
2007
pubmed:articleTitle
Irinotecan with 5-FU/FA in advanced biliary tract adenocarcinomas: a multicenter phase II trial.
pubmed:affiliation
Department of Internal Medicine II, University of Leipzig, Leipzig, Germany.
pubmed:publicationType
Journal Article, Multicenter Study, Clinical Trial, Phase II